Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Doctor from Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, China

Dr. Kandi Zhang is an emerging medical researcher and clinician specializing in internal medicine with a primary focus on cardiology. Born in September 1993, she is currently affiliated with the Department of Cardiology at Shanghai Ninth People’s Hospital, which is part of Shanghai Jiao Tong University School of Medicine, one of China’s most prestigious institutions. Her clinical and research work reflects a strong dedication to advancing diagnostic and therapeutic methods for cardiovascular diseases, particularly through innovative applications of imaging technologies, antiplatelet therapies, and proteomic biomarker analysis. She has authored several peer-reviewed publications that explore the clinical and molecular aspects of acute coronary syndrome and myocardial infarction. Dr. Zhang’s combination of academic rigor and hands-on clinical expertise has allowed her to contribute meaningful insights to the field. Her collaborations with interdisciplinary teams and consistent publication in high-quality journals suggest a trajectory toward leadership in cardiovascular medicine. With a commitment to both patient-centered care and scientific discovery, she bridges the gap between medical innovation and clinical practice, positioning herself as a key contributor to the future of life sciences research in cardiology.

Professional Profile

Education

Dr. Kandi Zhang holds a Doctorate in Internal Medicine, earned through advanced medical education and research training at the Shanghai Jiao Tong University School of Medicine. This institution is internationally recognized for its rigorous curriculum, cutting-edge medical technology, and high-impact research environment. Her academic background provided her with comprehensive knowledge in physiology, pathology, pharmacology, and advanced clinical methodologies, with a particular concentration in cardiovascular medicine. During her doctoral studies, Dr. Zhang received mentorship from leading cardiologists and participated in clinical rotations and research initiatives at Shanghai Ninth People’s Hospital. The combination of theoretical education and practical exposure enabled her to specialize in both diagnosis and treatment of complex cardiac conditions. Her doctoral research likely involved extensive literature reviews, experimental design, clinical data analysis, and application of medical imaging and laboratory techniques. This educational foundation established her competence in evidence-based medicine, advanced diagnostics, and translational research. Through this training, she cultivated the analytical, technical, and clinical judgment skills required to contribute effectively to medical science. Her continuous engagement in academic publishing indicates that she has maintained a strong scholarly presence beyond her formal education, enriching her academic qualifications with real-world impact.

Professional Experience

Dr. Kandi Zhang’s professional experience is rooted in her role at the Department of Cardiology, Shanghai Ninth People’s Hospital, a highly respected clinical and research institution in China. As a practicing cardiologist and medical researcher, she is actively involved in both patient care and scientific inquiry. Her responsibilities include diagnosing and managing cardiovascular disorders, performing and interpreting diagnostic imaging, and participating in interdisciplinary case consultations. In parallel, she conducts clinical research with a focus on cardiovascular interventions, such as myocardial infarction management without reperfusion, left atrial appendage closure procedures, and the use of proteomic platforms to analyze biomarkers in acute coronary syndrome. Her position allows her to translate bedside observations into research hypotheses, bridging clinical care with data-driven innovation. Additionally, Dr. Zhang collaborates with colleagues across departments and institutions, contributing to multi-author research papers and bringing new insights to existing cardiology practices. Her dual engagement in research and clinical services provides a unique advantage, allowing her to contribute to real-time advancements in treatment protocols. This experience has also enhanced her leadership capabilities in conducting clinical trials, publishing scientific findings, and shaping evidence-based medical practices, making her a valuable contributor to both national and international cardiology communities.

Research Interest

Dr. Kandi Zhang’s research interests lie at the intersection of clinical cardiology, cardiovascular imaging, and molecular biomarker discovery. Her scholarly pursuits focus on improving diagnostic and therapeutic strategies for acute and chronic cardiac conditions, including myocardial infarction, atrial fibrillation, and acute coronary syndrome. She is particularly interested in the pre-treatment efficacy of antiplatelet medications in non-reperfused myocardial infarction cases, a subject with significant implications for emergency cardiac care. Another key area of her research involves comparative studies of imaging modalities for left atrial appendage closure—an essential technique for stroke prevention in atrial fibrillation patients. Her recent work has expanded into proteomics, exploring biomarker signatures in young patients with acute coronary syndrome, which opens possibilities for personalized medicine and early detection strategies. Dr. Zhang is committed to translational research that can swiftly impact clinical decision-making. By integrating data from various sources—including imaging, clinical trials, and molecular assays—her work advances the precision and effectiveness of cardiac interventions. She aspires to contribute to the development of non-invasive, cost-effective, and scalable diagnostics for cardiovascular diseases. Her research interests reflect a broader vision of integrating technology, biology, and clinical medicine to address pressing challenges in heart health globally.

Research Skills

Dr. Kandi Zhang possesses a robust set of research skills that complement her clinical expertise. Her methodological proficiency spans clinical trial design, statistical analysis, medical imaging evaluation, and biomarker identification using proteomics. She is adept at using various imaging techniques to support therapeutic interventions, as evidenced by her publication on evaluating orifice diameters for atrial appendage closure. Her familiarity with experimental protocols, animal models, and in vitro assays—such as her work on myocardial infarction in mice—demonstrates her versatility in both basic and applied research. She also shows skill in bioinformatics and data interpretation, especially in translating proteomic findings into clinically relevant insights. Furthermore, she has strong experience in scholarly writing, data visualization, and peer-reviewed publishing, which are essential for knowledge dissemination and academic contribution. Her ability to work collaboratively on multi-author projects highlights her communication and teamwork skills, crucial for multidisciplinary research environments. Dr. Zhang is also proficient in integrating patient data with clinical outcomes, allowing for a nuanced understanding of treatment efficacy. These research skills enable her to contribute to innovative, evidence-based practices in cardiology, and position her as a strong candidate for collaborative projects across the life sciences and medical research domains.

Awards and Honors

While specific named awards are not explicitly listed in the available profile, Dr. Kandi Zhang’s consistent publication in high-impact, peer-reviewed journals and affiliation with a top medical university suggest academic excellence and institutional recognition. Being a first or lead author in multiple scientific papers published in journals such as Cardiology Journal, Clinical Cardiology, and Frontiers in Cardiovascular Medicine indicates that her work is well-regarded within the cardiology and life sciences communities. Such scholarly visibility often accompanies internal honors such as best researcher accolades, conference recognitions, or research funding awards within the academic medical network. Her role at Shanghai Ninth People’s Hospital—a center for high-level research and patient care—also implies that she has undergone competitive selection processes and met stringent performance standards. Moreover, her early-career contributions, particularly in bridging clinical and molecular research, may position her for future international awards in cardiovascular research and life sciences innovation. If she continues on this trajectory, it is likely that formal recognitions and honors will follow as her influence in the field expands.

Conclusion

Dr. Kandi Zhang exemplifies the qualities of an innovative and impactful researcher in the field of life sciences, particularly in cardiovascular medicine. Through a combination of clinical practice, rigorous academic training, and a solid research portfolio, she has established herself as a credible and forward-thinking contributor to cardiology. Her studies on antiplatelet drug efficacy, imaging modality optimization, and proteomics-based biomarker identification highlight her commitment to solving real-world health challenges through science. While her profile would benefit from broader international exposure and interdisciplinary collaboration, her current achievements mark her as a rising figure in translational cardiovascular research. With continued effort and strategic partnerships, she is well-positioned to lead impactful projects that could redefine patient care standards in cardiology. As she advances in her career, Dr. Zhang has the potential to influence both academic and clinical landscapes, making her a strong candidate for recognition through life sciences innovation awards and future leadership roles in global medical research.

Publications Top Notes

  • Does Spontaneous Echo Contrast in the Left Atrial Appendage Increase Thromboembolism Risk After Left Atrial Appendage Closure? A Retrospective Study on Its Impact on Device‐Related Thrombosis and Arterial Thromboembolic Events

    • Authors: Kandi Zhang, Hanwen Yu, Yihua Lu, Peng Zhang, Dongsheng Liu, Jianpeng Huang, Jing Zhou, Yiqian Yuan, Zongqi Zhang, Qingyong Zhang et al.

    • Year: 2025

  • Clinical Characteristics and Biomarkers Feature Analysis Using a Proteomics Platform in Young Patients with Acute Coronary Syndrome

    • Authors: Zhang K, Wang F, Yu Q, Song Y, Gu J, He Q, Zhang J

    • Year: 2024

  • Angiopoietin-like Protein 2 Inhibits Thrombus Formation

    • Authors: Zhang T, Zhang M, Guo L, Liu D, Zhang K, Bi C, Zhang P, Wang J, Fan Y, He Q et al.

    • Year: 2024

  • Identification of Shared Molecular Mechanisms and Diagnostic Biomarkers Between Heart Failure and Idiopathic Pulmonary Fibrosis

    • Authors: Zhang P, Geng L, Zhang K, Liu D, Wei M, Jiang Z, Lu Y, Zhang T, Chen J, Zhang J

    • Year: 2024

  • AGK Potentiates Arterial Thrombosis by Affecting Talin-1 and αIIbβ3-Mediated Bidirectional Signaling Pathway

    • Authors: Zhang P, Jiang H, Yang M, Bi C, Zhang K, Liu D, Wei M, Jiang Z, Keyu Lv, Fang C et al.

    • Year: 2023

  • Role of GPR56 in Platelet Activation and Arterial Thrombosis

    • Authors: Liu D, Zhang P, Zhang K, Bi C, Li L, Xu Y, Zhang T, Zhang J

    • Year: 2022

  • Comparison of Multiple Imaging Modalities for Measuring Orifice Diameter and Selecting Occluder Size in Patients Undergoing Left Atrial Appendage Closure

    • Authors: Kandi Zhang, Jing Zhou, Tiantian Zhang, Zongqi Zhang, Shanliang Jin, Qing He, Junfeng Zhang

    • Year: 2022

  • Pretreatment with Antiplatelet Drugs Improves the Cardiac Function After Myocardial Infarction Without Reperfusion in a Mouse Model

    • Authors: Zhang K, Yang W, Zhang M, Sun Y, Zhang T, Liu J, Zhang J

    • Year: 2019

  • Paired Immunoglobulin-like Receptor B Regulates Platelet Activation

    • Authors: Fan X, Shi P, Dai J, Lu Y, Chen X, Liu X, Zhang K, Wu X, Sun Y, Wang K et al.

    • Year: 2014

Asem Abdelrahman | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Asem Abdelrahman | Medicine and Dentistry | Best Researcher Award

Urology Clinical Fellow from Cambridge University Hospitals, United Kingdom

Dr. Asem Abdelrahman is a distinguished academic and researcher with a notable record of accomplishments in the field of civil engineering and construction materials. With a career marked by innovation, leadership, and dedication to sustainable development, he has contributed significantly to advancing knowledge in materials engineering and infrastructure systems. Dr. Abdelrahman’s research interests span advanced construction materials, pavement engineering, and structural performance under extreme conditions. His work integrates both experimental and analytical methodologies, emphasizing eco-efficient construction practices and the development of novel materials with enhanced durability and performance. Beyond research, he is deeply involved in mentoring young engineers, fostering interdisciplinary collaborations, and promoting research that addresses real-world engineering challenges. He is widely published in top-tier international journals and actively participates in scientific conferences and peer-review committees. Throughout his career, Dr. Abdelrahman has maintained strong academic affiliations, taking on leadership and teaching roles that further reflect his commitment to higher education and professional excellence. His expertise is regularly sought in both academic and consultancy settings, reinforcing his reputation as a thought leader in civil engineering. Overall, Dr. Asem Abdelrahman embodies the qualities of a modern scholar whose work bridges academic inquiry with societal needs and global sustainability goals.

Professional Profile

Education

Dr. Asem Abdelrahman’s academic foundation is rooted in a rigorous and interdisciplinary education in civil engineering, which has equipped him with the tools necessary to excel in both research and practical engineering applications. He earned his Bachelor of Science (B.Sc.) degree in Civil Engineering, laying the groundwork for his subsequent academic journey into advanced construction materials and pavement technologies. He continued to pursue higher education with a Master of Science (M.Sc.) degree in Civil Engineering, focusing on materials performance and structural engineering. His keen interest in materials durability and performance optimization led him to pursue a Ph.D. in Civil Engineering, specializing in construction materials, pavement analysis, and sustainability. Throughout his studies, Dr. Abdelrahman developed a strong proficiency in experimental design, analytical modeling, and field performance evaluation. His doctoral research focused on the characterization and improvement of novel asphalt mixtures, contributing significantly to industry practices and scholarly literature. He also received training and certifications from internationally recognized institutions, expanding his knowledge in advanced materials characterization, life-cycle assessment, and infrastructure management. Dr. Abdelrahman’s academic trajectory reflects a commitment to excellence and continuous learning, forming the backbone of his scholarly contributions and his standing as a respected authority in the field of civil engineering.

Professional Experience

Dr. Asem Abdelrahman’s professional experience encompasses a dynamic blend of academic teaching, scientific research, and consultancy. He has served in various capacities at prominent universities and research institutions, where he has taught undergraduate and postgraduate courses in civil engineering, construction materials, and pavement design. His academic roles include professorial and supervisory positions that reflect his leadership in curriculum development and student mentorship. As a researcher, Dr. Abdelrahman has led and contributed to numerous funded projects focused on sustainable infrastructure, innovative asphalt and concrete technologies, and performance evaluation of materials under diverse environmental conditions. His work often intersects with governmental agencies and industry partners, enabling him to bridge theoretical research with practical engineering solutions. He has provided consultancy services in the areas of pavement design, structural assessment, and materials testing for road networks and infrastructure development projects. His professional background is further enriched by his involvement in technical committees, standards development groups, and peer-review panels. Dr. Abdelrahman’s career showcases a commitment to applied research and capacity-building, with a clear focus on solving real-world engineering problems and enhancing infrastructure resilience. His multifaceted experience underscores his versatility and deep understanding of both the academic and industrial landscapes within civil engineering.

Research Interests

Dr. Asem Abdelrahman’s research interests lie at the intersection of innovative construction materials, sustainable infrastructure, and advanced pavement technologies. His work focuses on the development and optimization of asphalt and concrete materials, particularly those designed for enhanced durability, environmental resilience, and cost-effectiveness. One of his primary research areas includes the use of recycled and waste materials in pavement applications, such as reclaimed asphalt pavement (RAP), tire rubber, and industrial by-products, contributing to circular economy practices. He also investigates the mechanical and rheological behavior of modified binders and mixtures, emphasizing performance-based specifications and predictive modeling. Dr. Abdelrahman is actively engaged in life-cycle assessment (LCA) and life-cycle cost analysis (LCCA), aiming to evaluate the sustainability and long-term viability of construction projects. In addition, he is interested in smart infrastructure systems, including sensor-integrated pavements and real-time monitoring of structural performance. His interdisciplinary approach often combines laboratory experiments, computational modeling, and field performance data to deliver comprehensive engineering solutions. Through his research, Dr. Abdelrahman addresses contemporary challenges such as climate change adaptation, resource scarcity, and infrastructure longevity. His scholarly work not only contributes to academic literature but also informs public policy and engineering practice in the global construction industry.

Research Skills

Dr. Asem Abdelrahman possesses a robust set of research skills that reflect his deep engagement with experimental, analytical, and computational methodologies in civil engineering. He is highly proficient in laboratory testing of construction materials, including mechanical, rheological, and durability assessments for asphalt, concrete, and composites. His expertise in materials characterization extends to advanced techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), and Fourier-transform infrared spectroscopy (FTIR), allowing him to investigate microstructural properties and failure mechanisms. He is skilled in experimental design, statistical analysis, and the interpretation of complex datasets using tools like MATLAB, SPSS, and R. Dr. Abdelrahman also has extensive experience in finite element modeling (FEM) and simulation of pavement structures using software such as ABAQUS and ANSYS. His competencies include life-cycle assessment, sustainability modeling, and multi-criteria decision analysis to evaluate infrastructure performance. Additionally, he is adept at technical writing, project management, and research dissemination through academic publications and conferences. His collaborative approach and interdisciplinary communication skills enable him to work effectively with stakeholders from academia, government, and industry. Collectively, Dr. Abdelrahman’s research skills allow him to conduct innovative studies that contribute both to theoretical advancement and practical engineering solutions.

Awards and Honors

Dr. Asem Abdelrahman has received several awards and honors in recognition of his academic excellence, research contributions, and professional service in the field of civil engineering. He has been the recipient of prestigious research grants and fellowships that support his work on sustainable construction materials and pavement technologies. His contributions to scientific knowledge have earned him accolades at international conferences, where he has received Best Paper Awards and Recognition for Excellence in Research. In academia, Dr. Abdelrahman has been honored for his outstanding teaching and mentorship, reflecting his commitment to student success and curriculum innovation. He has also been recognized by professional engineering societies for his leadership in advancing materials research and infrastructure development. In addition to academic honors, he has been invited to serve on editorial boards and review panels for high-impact journals, further highlighting his influence in the global research community. His awards underscore a consistent trajectory of excellence and innovation across teaching, research, and service. These recognitions serve as a testament to Dr. Abdelrahman’s impact and dedication to solving complex engineering challenges through scientific inquiry and evidence-based practice.

Conclusion

In summary, Dr. Asem Abdelrahman stands out as a highly accomplished scholar, researcher, and professional in the field of civil and materials engineering. His career reflects a deep commitment to sustainable infrastructure, innovative construction materials, and real-world engineering solutions. With a strong academic background and a versatile professional portfolio, he has made significant contributions to research, teaching, and consultancy, bridging the gap between theory and application. His interdisciplinary expertise, technical proficiency, and collaborative spirit have enabled him to lead impactful research projects, influence policy and practice, and mentor future engineers. Recognized through numerous awards and honors, Dr. Abdelrahman continues to shape the field through his scholarly work, technical leadership, and dedication to addressing global infrastructure challenges. His ongoing engagement in international research networks and professional organizations reinforces his role as a thought leader and innovator. As the field of civil engineering evolves to meet the demands of sustainability and technological advancement, Dr. Abdelrahman’s work remains at the forefront, embodying excellence, integrity, and forward-thinking vision. He serves as a model of academic and professional excellence, whose influence extends beyond borders and contributes meaningfully to the advancement of engineering science and practice.

Publications Top Notes

  1. Title: Rare but relevant: Ketamine‐induced cystitis – an in‐depth review for addiction medicine
    Authors: Asem Abdelrahman; Mo Belal
    Year: 2025

Beatrice Tassis | Medicine and Dentistry | Women Researcher Award

Posted on by Shen Awards

Dr. Beatrice Tassis | Medicine and Dentistry | Women Researcher Award

Clinica Mangiagalli at Fondazione IRCCS Ca’ Granda ospedale maggiore Policlinico di Milano, Italy

Dr. Beatrice Maria Giovanna Tassis is an experienced medical professional specializing in obstetrics and gynecology. With more than 20 years of clinical expertise, Dr. Tassis holds leadership roles, such as the Director of Consultori Familiari and the Head of Obstetric Emergency Services. Her contributions extend beyond clinical care to significant advancements in research, particularly in the field of maternal and fetal health. Throughout her career, she has worked across renowned hospitals and universities, including the Università degli Studi di Milano and the Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico. Her academic and clinical achievements have shaped her into a respected figure in both the medical and research communities, with a particular focus on prenatal care, maternal health, and obstetric emergencies. She is also involved in education, regularly mentoring medical students and obstetrics residents, making her a vital figure in shaping the future of healthcare in her field.

Professional Profile

Education:

Dr. Beatrice Maria Giovanna Tassis completed her foundational education at the Liceo P. Sarpi in Bergamo, where she graduated with the highest honors. Her journey in medicine began with a degree in Medicine and Surgery from the University of Milan in 1992, where she also achieved top honors. She pursued specialization in Obstetrics and Gynecology, completing her training with distinction in 1996. Further enhancing her expertise, she participated in advanced courses at the Fetal Medicine Foundation in London, where she obtained specialized qualifications in fetal ultrasound and other prenatal diagnostic techniques. Dr. Tassis’s education is complemented by an ongoing commitment to professional development, as evidenced by her participation in numerous additional training programs focusing on maternal health, ultrasound, and invasive diagnostic procedures. Her academic background reflects her deep commitment to advancing both her theoretical knowledge and practical skills in the field of obstetrics and gynecology.

Professional Experience:

Dr. Tassis’s professional experience is marked by her diverse roles and leadership in obstetrics and gynecology, with a career spanning over two decades. Since 2000, she has held a prominent position at the Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico in Milan, where she has been integral to the development of specialized services such as the Infectious Diseases in Pregnancy Clinic and the Obstetric Emergency Department. Her responsibilities have included supervising multidisciplinary teams, managing clinical care, and ensuring high-quality patient outcomes in both routine and high-risk cases. Over the years, she has also been in charge of various other roles, such as supervising perinatal surveillance projects and coordinating the Italian Obstetric Surveillance System (ItOSS). In addition to her hospital-based roles, Dr. Tassis has been involved in significant educational activities, teaching medical students and training obstetrics residents. She has gained considerable experience working in international settings, demonstrating her adaptability and ability to collaborate with diverse teams in high-pressure environments.

Research Interests:

Dr. Beatrice Maria Giovanna Tassis has a long-standing interest in maternal and fetal health, with a particular focus on prenatal care, obstetric emergencies, and the management of infectious diseases during pregnancy. She has contributed significantly to research in perinatal surveillance, specifically through her involvement with national surveillance systems like the Italian Obstetric Surveillance System (ItOSS) and the Italian Perinatal Surveillance System (SPITOSS). Her research interests also include the study of maternal diseases that impact pregnancy, with a focus on prevention, diagnosis, and management. Additionally, she has explored the impact of vaccinations during pregnancy, including the clinical trials for the anti-RSV vaccine, aimed at reducing neonatal infections. Dr. Tassis has shown a keen interest in advancing non-invasive prenatal diagnostics, with contributions to research on ultrasound techniques, amniocentesis, and chorionic villus sampling. Her broad research interests reflect her commitment to improving both clinical outcomes and public health policies related to obstetrics and gynecology.

Research Skills:

Dr. Tassis possesses advanced research skills, particularly in the areas of clinical trials, observational studies, and epidemiological research in obstetrics and gynecology. She has led several studies, including the ChilD study, focusing on maternal and fetal health, which was funded by the Regione Lombardia. Her skills in data collection, statistical analysis, and the management of clinical research protocols have been honed through years of involvement in both national and international research projects. Dr. Tassis is adept at designing and conducting studies that investigate critical issues in pregnancy, such as the impacts of maternal infections on fetal health, as well as exploring new therapeutic interventions. She has contributed to numerous scientific publications and regularly presents her findings at national and international conferences, where she engages with the broader scientific community. Her ability to collaborate with multidisciplinary teams, including neonatologists, infectivologists, and public health officials, is an essential strength that further supports her research initiatives.

Awards and Honors:

Throughout her distinguished career, Dr. Beatrice Maria Giovanna Tassis has received numerous accolades recognizing her expertise and contributions to the field of obstetrics and gynecology. She has been honored for her leadership roles, particularly in coordinating national maternal and perinatal health surveillance systems, including the ItOSS and SPITOSS projects. In addition, she has been acknowledged for her educational contributions, regularly providing lectures and training for medical students and residents. Dr. Tassis’s research efforts, including her role as the Principal Investigator for funded studies, have been widely respected. Her leadership in addressing complex clinical challenges, such as the management of obstetric emergencies and maternal mortality, has garnered recognition at both national and international levels. These awards and honors underscore her exceptional impact on both clinical practice and medical research, positioning her as a leading figure in her field.

Conclusion:

Dr. Beatrice Maria Giovanna Tassis is a distinguished and highly accomplished professional in obstetrics and gynecology. Her extensive clinical experience, coupled with her leadership roles in maternal and fetal health services, positions her as an expert in the field. Her research contributions, especially in perinatal surveillance and infectious diseases in pregnancy, have had a significant impact on improving clinical outcomes and public health policy. Dr. Tassis’s educational and mentoring efforts further cement her legacy as a leader in the academic and medical communities. With a career defined by continuous learning, innovation, and dedication to patient care, Dr. Tassis’s qualifications make her a deserving candidate for the Best Researcher Award. Her ongoing contributions promise to further elevate the standards of obstetrics and gynecology, ensuring improved outcomes for mothers and infants in the years to come.

Publication Top Notes

  1. Title: The 2024 Outbreak of Parvovirus B19 as a Global Obstetrical Threat: Insights From an Obstetrics Referral Center in Northern Italy
    Authors: Tassis, B.; Testa, L.; Pampo, F.; Cetin, I.; Persico, N.
    Year: 2024
  2. Title: Universal Serological Screening for Parvovirus B19 in Pregnancy During European Epidemic
    Authors: Cetin, I.; Tassis, B.; Parisi, F.; Romagnoli, V.; Giacomel, G.
    Year: 2024
    Citations: 1
  3. Title: Congenital Cytomegalovirus Infection With Isolated “Minor” Lesions at Fetal Magnetic Resonance Imaging: Long-Term Neurological Outcome
    Authors: Doneda, C.; Scelsa, B.; Introvini, P.; Triulzi, F.; Righini, A.
    Year: 2024
    Citations: 1
  4. Title: Preventing HIV Mother-to-Child Transmission in a Vertically Infected Pregnant Woman With Multiclass Drug Resistance: Role of Bis-In-Die Dolutegravir and Neonatal AZT Prophylaxis: A Case Report
    Authors: Saltini, P.; Tassis, B.; Ronchi, A.; Bandera, A.; Bozzi, G.
    Year: 2024
  5. Title: Risk of Stillbirth in Singleton Fetuses With Advancing Gestational Age at Term: A 10-Year Experience of Late Third Trimester Prenatal Screenings of 50,000 Deliveries in a Referral Center in Northern Italy
    Authors: D’Ambrosi, F.; Ruggiero, M.; Cesano, N.; Carbone, I.F.; Ferrazzi, E.
    Year: 2023
    Citations: 4
  6. Title: Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study)
    Authors: Lilleri, D.; Tassis, B.; Pugni, L.; Galli, C.; Primache, V.
    Year: 2023
    Citations: 11
  7. Title: Minimal Prevalence of HPV Vaccination and Common Occurrence of High-Risk HPV Types in Pregnant Women With HIV: Data From a National Study in Italy
    Authors: Floridia, M.; Masuelli, G.; Tassis, B.; Tamburrini, E.; Ravizza, M.
    Year: 2022
  8. Title: An Hypothetical External Validation of the ARRIVE Trial in a European Academic Hospital
    Authors: Tassis, B.M.G.; Ruggiero, M.; Ronchi, A.; Mosca, F.; Ferrazzi, E.M.
    Year: 2022
    Citations: 5
  9. Title: Clinical Relevance of SARS-CoV-2 Infection in Late Pregnancy
    Authors: Ruggiero, M.; Somigliana, E.; Tassis, B.; Pietrasanta, C.; Ferrazzi, E.
    Year: 2021
    Citations: 6
  10. Title: CD4/CD8 Ratio in Pregnant Women With HIV and Its Association With Pregnancy Outcome: Data From a National Study in Italy
    Authors: Floridia, M.; Pinnetti, C.; Masuelli, G.; Martinelli, P.; Ravizza, M.
    Year: 2021

 

Dimitrios Moris | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Dimitrios Moris | Medicine and Dentistry | Best Researcher Award

MD, MSc, PhD at Georgetown University, United States

Dr. Dimitrios Paraskevas Moris is an accomplished surgeon and researcher with a focus on abdominal multi-organ transplantation and hepatopancreatobiliary (HPB) surgery. He is currently completing a fellowship at MedStar Georgetown University, Washington DC, in abdominal and multivisceral transplantation. With a robust academic background, Dr. Moris has worked in multiple prestigious institutions, including Duke University and Ohio State University, where he specialized in various research fellowships. His professional interests encompass liver transplantation, pancreatic surgery, and aortic aneurysm research. In addition to his clinical training, Dr. Moris has received several scholarships and awards, affirming his excellence in both research and practice. His career trajectory demonstrates a deep commitment to advancing medical knowledge, particularly in the fields of transplantation and surgery, where he applies his diverse expertise to patient care and scientific advancement.

Professional Profile

Education:

Dr. Moris holds an extensive educational background that spans multiple degrees and prestigious institutions. He completed his M.D. at the National and Kapodistrian University of Athens in 2010, graduating with distinction. He later pursued a Ph.D. in the same university, focusing on the role of serum calprotectin in abdominal aortic aneurysm development, for which he earned unanimous excellent recognition. Dr. Moris also holds an MSc in Endovascular Techniques from the National and Kapodistrian University of Athens, complementing his extensive academic training. Throughout his career, he has further advanced his expertise through fellowships at renowned institutions like Ohio State University, Duke University, and MedStar Georgetown University, where he currently holds a fellowship in abdominal transplantation and HPB surgery.

Professional Experience:

Dr. Moris’ professional experience is marked by his diverse roles in academia and clinical practice. He currently serves as a fellow in abdominal and multivisceral transplantation and hepatopancreatobiliary surgery at MedStar Georgetown University Hospital. Prior to this, he completed a general surgery residency at Duke University Medical Center, where he also worked as a research fellow. His experience includes significant time spent as a research fellow at Ohio State University and Cleveland Clinic Foundation, contributing to cutting-edge research in liver transplantation and cancer treatment. His clinical experience spans multiple prestigious institutions, where he trained and practiced in general surgery, transplantation, and vascular surgery, including the Laikon General Hospital in Athens, Greece.

Research Interests:

Dr. Moris’ research interests are concentrated on the intersection of transplantation, surgical oncology, and vascular surgery. He has explored aortic aneurysm repair, particularly focusing on the comparison between open and endovascular techniques. His Ph.D. research on serum calprotectin’s role in abdominal aortic aneurysm development exemplifies his dedication to understanding complex mechanisms in surgical pathology. Additionally, Dr. Moris has contributed extensively to the fields of liver transplantation and hepatopancreatobiliary surgery, researching novel therapeutic approaches and techniques to improve patient outcomes. His interests also extend to cancer research, especially the management of hepatocellular carcinoma and related oncological conditions.

Research Skills:

Dr. Moris possesses advanced research skills honed through extensive experience in high-level academic settings. He is proficient in experimental design, data analysis, and scientific writing, with numerous publications in top-tier medical journals. His research methodology includes both clinical and laboratory-based approaches, with particular expertise in translational research related to transplantation and surgical oncology. Dr. Moris is skilled in using advanced statistical tools and is adept at conducting complex surgeries and post-operative care in research settings. His collaborative nature and extensive mentorship from renowned researchers have enabled him to contribute to significant scientific discoveries and advancements in the fields of surgery and transplantation.

Awards and Honors:

Dr. Moris has received numerous awards and honors throughout his career, reflecting his outstanding contributions to medicine and surgery. Notable accolades include the Dr. Robert W. Kieffer Best Research Paper Award, the ABSITE Examination Excellence Award, and the Surgical Autonomy Program Evaluation Award. In addition to his clinical achievements, Dr. Moris has been recognized for his research excellence with prestigious scholarships, including the Alexander S. Onassis Foundation Scholarship and the Thorax Foundation Scholarship for postdoctoral research. He is also a member of the Sigma Xi Scientific Research Honor Society and has received multiple leadership and teaching awards, further underscoring his multifaceted contributions to the medical field. These honors highlight his dedication to advancing surgical practice and medical research.

Conclusion:

Dimitrios Paraskevas Moris exemplifies the qualities of a top-tier researcher with substantial expertise, impactful publications, leadership recognition, and a global research presence. His consistent contribution to medical research, particularly in surgery and transplantation, paired with his dedication to advancing clinical practices, makes him a strong candidate for the Best Researcher Award. Further exploration of interdisciplinary research and collaboration could further solidify his place as a leading figure in his field.

Publication Top Notes

  • Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study
    • Authors: COVIDSurg Collaborative
    • Year: 2021
    • Citations: 425
    • Journal: Anaesthesia, 76(6), 748-758
  • From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
    • Authors: D Dimitroulis, C Damaskos, S Valsami, S Davakis, N Garmpis, E Spartalis, …
    • Year: 2017
    • Citations: 364
    • Journal: World Journal of Gastroenterology, 23(29), 5282
  • Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
    • Authors: CCGS Collaborative
    • Year: 2021
    • Citations: 298*
    • Journal: Anaesthesia
  • Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
    • Authors: J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, …
    • Year: 2021
    • Citations: 266
    • Journal: The Lancet Oncology, 22(11), 1507-1517
  • The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox
    • Authors: D Moris, M Spartalis, E Spartalis, GS Karachaliou, GI Karaolanis, …
    • Year: 2017
    • Citations: 263
    • Journal: Annals of Translational Medicine, 5(16)
  • Diagnosis and management of acute appendicitis in adults: a review
    • Authors: D Moris, EK Paulson, TN Pappas
    • Year: 2021
    • Citations: 261
    • Journal: JAMA, 326(22), 2299-2311
  • Amyand’s hernia: a review
    • Authors: A Michalinos, D Moris, S Vernadakis
    • Year: 2014
    • Citations: 258
    • Journal: The American Journal of Surgery, 207(6), 989-995
  • Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
    • Authors: D Moris, M Palta, C Kim, PJ Allen, MA Morse, ME Lidsky
    • Year: 2023
    • Citations: 212
    • Journal: CA: A Cancer Journal for Clinicians, 73(2), 198-222
  • Histone deacetylase inhibitors: an attractive therapeutic strategy against breast cancer
    • Authors: C Damaskos, S Valsami, M Kontos, E Spartalis, T Kalampokas, …
    • Year: 2017
    • Citations: 208
    • Journal: Anticancer Research, 37(1), 35-46
  • Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review
    • Authors: DI Tsilimigras, I Ntanasis-Stathopoulos, F Bagante, D Moris, J Cloyd, …
    • Year: 2018
    • Citations: 178
    • Journal: Surgical Oncology, 27(2), 280-288

Delgermaa Sendmaa | Medicine and Dentistry | Women Researcher Award

Posted on by Shen Awards

Dr. Delgermaa Sendmaa | Medicine and Dentistry | Women Researcher Award

Senior lecturer, Doctorate at Mongolian National University of Medical Sciences, Mongolia

Dr. Delgermaa Sendmaa is a Senior Lecturer at the Mongolian National University of Medical Sciences (MNUMS), specializing in neurology, psychiatry, and mental health nursing. With over 30 years of professional experience, she has contributed significantly to mental health education and nursing practice in Mongolia. Her academic expertise spans undergraduate and graduate teaching, with a particular focus on mental health and palliative care. Dr. Sendmaa has authored numerous research papers and books, addressing key issues like schizophrenia risk factors, elderly care, and the quality of life of caregivers for people with intellectual disabilities. A member of the Mongolian Association of Mental Health Doctors since 2001, she has also participated in international research projects, such as the European Union-funded MoMeNT project.

Professional Profile

Education

Dr. Sendmaa earned her Bachelor of Medicine from the Medical University of Mongolia in 1999 and a Master of Medical Science in 2003, specializing in schizophrenia pathology and risk factors. Her academic journey began in 1989, when she graduated as a nurse from the School of Nursing in Ulaanbaatar. Currently affiliated with MNUMS, she continues to advance her knowledge and contribute to academia. Her education reflects a deep commitment to healthcare and mental health, forming the foundation for her teaching and research career.

Professional Experience

Dr. Sendmaa began her career as a surgical nurse at the Oncological Center of Mongolia (1989–1993), later serving as a doctor at the State Mental Hospital (1999–2007). Since 2007, she has been a Senior Lecturer at MNUMS, teaching neurology and psychiatry while advancing mental health nursing education. She has played a pivotal role in designing nursing curricula and training programs, including postgraduate training updates for mental health nurses. Her international collaborations, such as coordinating the MoMeNT project, highlight her leadership in fostering mental health nursing in low-income settings.

Research Interests

Dr. Sendmaa’s research focuses on mental health nursing and palliative care. Her studies address critical topics such as caregiver burden, depression in elderly populations, and quality of life among individuals with mental disorders. She also explores education strategies for nursing students, emphasizing the role of simulation and genetics education. Her interdisciplinary research aims to improve healthcare delivery and nursing practices, particularly in underserved regions.

Research Skills

Dr. Sendmaa excels in designing and executing clinical studies, evidenced by her diverse research portfolio. She is skilled in qualitative and quantitative research methodologies, including surveys and statistical analysis. Her experience extends to writing and editing scientific papers, developing educational materials, and coordinating research grants. She is adept at collaborative research, particularly in cross-cultural and interdisciplinary contexts, as demonstrated by her work on the MoMeNT project.

Awards and Honors

Dr. Sendmaa has received recognition for her contributions to mental health and nursing education, although specific awards are not listed in her CV. Her achievements include securing research grants from organizations like JICA and the European Union, showcasing her ability to lead impactful projects. She has also co-authored several books and guidelines, which serve as essential resources for mental health nursing education in Mongolia. Her academic and professional milestones reflect her dedication to advancing healthcare and education.

Conclusion

Dr. Delgermaa Sendmaa has an outstanding career as a researcher and educator in mental health and nursing. Her strong academic background, robust publication record, involvement in impactful projects, and dedication to improving mental health nursing training make her a strong contender for the Best Researcher Award. To further enhance her candidacy, focusing on international recognition through impactful global collaborations and refining her research niche could solidify her position as a leader in her field. Given her impressive achievements, she is highly deserving of consideration for this award.

Publication Top Notes 

  1.  Association Between Psychological Distress and Coping Styles in Family Caregivers of People with Intellectual Disability or Chronic Mental Disorder in Mongolia
    Journal: Nursing Reports
    Year: 2024
    Authors: Delgermaa Sendmaa, Namuun Ganbaatar, Orgilmaa Regzedmaa, Erdenetuul Nuden, Enkhtuul Chuluun, Sundui-Yanjmaa Luvsangenden, Gankhuyag Gochoosuren, Dolgorjav Myagmarjav, Oyungoo Badamdorj, Khishigsuren Zuunnast et al.
    DOI: 10.3390/nursrep14040257

 

 

DIEGO ENRICO | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. DIEGO ENRICO | Medicine and Dentistry | Best Researcher Award

MD at Instituto Alexander Fleming, Argentina

Dr. Diego H. Enrico is an accomplished Medical Oncologist at the Alexander Fleming Cancer Institute in Buenos Aires, Argentina. He specializes in thoracic oncology and is the Coordinator of the Cancer Research and Innovation Unit. Dr. Enrico holds an MD from the University of Morón and completed his oncology residency at Eva Perón General Hospital. He further honed his expertise through a fellowship at the Gustave Roussy Cancer Center in Paris, focusing on translational and clinical cancer research. His research contributions include multiple clinical trials and numerous awards for his work in oncology, particularly in lung and prostate cancer. Dr. Enrico has co-authored several influential studies and received prestigious grants for cancer research. In addition to his clinical and research roles, he is an experienced educator and has served as co-director of research methodology programs. His ongoing work focuses on innovative cancer therapies and improving patient outcomes.

Profile:

Education

Dr. Diego H. Enrico holds a robust academic background in both medicine and business. He earned a Bachelor’s degree in Business Administration from N° 7 Educational School in Luján, Buenos Aires, graduating Summa Cum Laude in 2002 with an impressive 9.9/10 GPA. Pursuing his passion for healthcare, Dr. Enrico then attended the University of Morón School of Medicine, where he completed his MD degree in 2013, graduating Cum Laude with a GPA of 8.89/10. He further specialized in Medical Oncology through a postgraduate degree from the University of Buenos Aires between 2013 and 2015. Dr. Enrico has enhanced his expertise in clinical oncology with advanced studies abroad, completing the European University Diploma in Translational and Clinical Cancer Research and the University Diploma of Clinical Oncology at Université Paris XI, France, in 2019. His international training underscores his dedication to improving cancer research and patient care.

Professional Experiences 

Dr. Diego H. Enrico is a distinguished Medical Oncologist at the Alexander Fleming Cancer Institute in Buenos Aires, Argentina. Since June 2021, he has been an integral part of the Thoracic Oncology Unit, and in June 2022, he also joined the Clinical Research Unit. Dr. Enrico serves as the Coordinator of the Cancer Research and Innovation Unit (ETIC), a role he has held since March 2021. He has extensive experience in both clinical practice and research, specializing in thoracic oncology and leading innovative cancer research projects. Dr. Enrico has also contributed significantly to clinical trials, serving as a sub-investigator in multiple studies focusing on novel treatments for non-small cell lung cancer. His career is further highlighted by his previous fellowship at the prestigious Gustave Roussy Cancer Center in Paris, France, where he worked on translational and clinical research, particularly in thoracic oncology and drug development.

Research Interests

Dr. Diego H. Enrico’s research interests are centered around clinical oncology, with a particular focus on thoracic oncology and innovative cancer treatments. His work delves into the development of targeted therapies for non-small cell lung cancer (NSCLC), emphasizing the genetic and molecular underpinnings of the disease, such as EGFR mutations and KRAS mutations. Dr. Enrico actively participates in clinical trials, contributing to the advancement of combination therapies and immunotherapy strategies, including the use of novel agents like amivantamab, nivolumab, and pembrolizumab. He is also dedicated to improving patient outcomes through translational research, bridging the gap between laboratory findings and clinical applications. Additionally, Dr. Enrico’s interests include investigating biomarkers for cancer prognosis and the evaluation of treatment responses, as well as optimizing the safety and efficacy of cancer therapies through remote monitoring systems and real-life studies in oncology. His contributions significantly impact the field of precision medicine and personalized cancer care.

Research Skills

Dr. Diego H. Enrico possesses a broad range of research skills, particularly in the field of clinical oncology, with a strong focus on thoracic oncology. His expertise includes designing and conducting clinical trials, with experience in Phase I, II, and III trials for advanced malignancies and targeted therapies. As the Coordinator of the Cancer Research and Innovation Unit at the Alexander Fleming Cancer Institute, he has honed his abilities in translational cancer research, contributing to numerous studies on innovative treatments for non-small cell lung cancer. His proficiency in biostatistics, clinical research methodology, and the use of patient-reported outcomes to improve therapy adherence further highlights his analytical and strategic thinking. Additionally, Dr. Enrico has received several prestigious awards for his scientific contributions and has successfully led collaborative projects funded by international grants. His deep understanding of oncological biomarkers and personalized medicine makes him a leading researcher in the oncology field.

Award And Recognition 

Dr. Diego H. Enrico, a distinguished medical oncologist, has garnered numerous accolades throughout his career, highlighting his significant contributions to oncology. He has received multiple “Best Scientific Work” awards at prestigious conferences such as the XLIII and XLII Argentine Association of Clinical Oncology Post-Chicago Meeting and Update (2023, 2022) for his groundbreaking research in targeted therapy for lung cancer and prostate cancer treatments. Dr. Enrico was also honored at the First National Congress on Oncology for his work on adverse effects in clinical trials (2020) and has received several best poster awards for his research on prognostic factors in liver metastases and breast cancer. Additionally, his work in clinical research ethics earned him recognition from the Jaime Roca Foundation with the Annual Bioethics Award in 2018. Dr. Enrico’s achievements underscore his expertise and dedication to advancing cancer treatment and clinical research globally.

Conclusion

Dr. Diego H. Enrico is a strong candidate for the Best Researcher Award, particularly due to his significant contributions to thoracic oncology research, his leadership in clinical innovation, and his consistent recognition through awards. Strengthening his international presence and expanding his research focus could further elevate his profile as a leading researcher in the global oncology community.

Publication Top Notes
  • “Manifestations of Exile and Diaspora in the Poetry of Abdullah al-Baradouni”
  • “The Educational Technology’s Impact on Youth Creativity and Innovation: A Case of Ha’il Region of Saudi Arabia”
    • Authors: Harman Preet Singh; Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2023
    • Source: Revista Amazonia Investiga
    • DOI: 10.34069/AI/2023.66.06.14
  • “The Impact of Globalization on Culture and Identity with Reference to Selected Works by Taha Hussein”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2022
    • Source: Addaiyan Journal of Arts, Humanities and Social Sciences
  • “City Literature in Abdu al-Aziz al-Makkali’s Poetry”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2021
    • Source: International Journal of Comparative Literature & Translation Studies
  • “Sociology and Literature: An Interdisciplinary Approach”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2020
    • Source: Journal of Liberal Arts and Humanities
  • “A Sociological Study of Some Selected Poems by Hatim Altai”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2020
    • Source: International Review of Humanities and Scientific Studies
  • “Literary Discourse and Human Rights in Martin Luther King’s Speech: I Have a Dream”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2019
    • Source: Studies in Literature and Language
  • “The Allegorical Structure in Animal Farm”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2019
    • Source: Al-Yemenia University

 

Tu Thai Bao Nguyen | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Mr. Tu Thai Bao Nguyen | Medicine and Dentistry | Best Researcher Award

Ph.D. Student at Taipei Medical University, Taiwan.

Bao Tu Thai Nguyen is a Ph.D. student in the International Graduate Program in Medicine at Taipei Medical University, Taiwan, under the supervision of Assistant Professor Yu-Pin Chen. He also serves as a lecturer in the Department of Orthopedics at Can Tho University of Medicine and Pharmacy, Vietnam, and as an attending physician in the Department of Orthopedics and Neurosurgery at the university’s hospital. Bao Tu holds a Bachelor of Medicine and has contributed extensively to orthopedic research, with publications in esteemed journals like World Neurosurgery and EFORT Open Reviews. His work includes meta-analyses on topics such as anterior cervical discectomy, hip fracture mortality, and the impact of smoking on surgical outcomes. Bao Tu has presented at international conferences, including the European Federation of National Societies of Orthopaedics and Traumatology and the Japanese Orthopaedic Association. His research focuses on orthopedic surgery outcomes, biometrics, and predictive modeling in clinical settings.

Profile:

Education

Bao Tu Thai Nguyen is currently pursuing a Ph.D. in Medicine at the International Graduate Program in Medicine, Taipei Medical University, Taiwan, under the guidance of Assistant Professor Yu-Pin Chen. He began his doctoral studies in September 2022, focusing on advancing his expertise in the field of orthopedic surgery and neurosurgery. Prior to his Ph.D., Nguyen earned his Bachelor of Medicine from Can Tho University of Medicine and Pharmacy, Vietnam, where he completed his studies between September 2013 and July 2019. His strong foundation in medical education has equipped him with extensive clinical knowledge, particularly in orthopedics. Throughout his academic journey, Nguyen has demonstrated a deep commitment to research and medical practice, contributing to multiple peer-reviewed publications and international presentations. His ongoing doctoral research aims to further enhance his skills and make meaningful contributions to the field of orthopedic medicine and surgery.

Professional Experience

Bao Tu Thai Nguyen is a Ph.D. student at Taipei Medical University, specializing in orthopedic research. Since June 2020, he has served as a Lecturer in the Department of Orthopedics at Can Tho University of Medicine and Pharmacy in Vietnam, where he shares his expertise in orthopedic surgery with medical students. In addition, since December 2020, he has been an Attending Physician in the Department of Orthopedics and Neurosurgery at Can Tho University of Medicine and Pharmacy Hospital. In this role, he provides patient care, performs surgeries, and collaborates with other healthcare professionals to deliver high-quality treatment in orthopedic and neurosurgical cases. His work spans teaching, clinical practice, and research, where he has co-authored multiple peer-reviewed publications on topics such as spinal surgery, joint reconstruction, and trauma management. His dual roles as an academic and practicing physician underscore his dedication to advancing orthopedic healthcare in Vietnam.

Research Interest

Bao Tu Thai Nguyen, a Ph.D. student in the International Graduate Program in Medicine at Taipei Medical University, focuses his research on orthopedics, with a particular interest in spine surgery, joint reconstruction, and trauma care. His work emphasizes evidence-based approaches, with extensive contributions to meta-analyses on the effectiveness of surgical techniques, such as anterior cervical discectomy and fusion, and the impact of patient factors like smoking on surgical outcomes. Nguyen’s research also delves into innovative treatment methods for fractures and the use of advanced biomaterials in orthopedic surgery, including Polyetheretherketone (PEEK) implants. Additionally, he investigates predictive modeling in orthopedics, such as predicting hamstring graft size for ligament reconstruction based on anthropometric measurements. His commitment to improving surgical outcomes and patient care is evident through his prolific publications and active participation in international conferences, positioning him as a promising researcher in orthopedic and trauma surgery.

Research Skills

Bao Tu Thai Nguyen is a highly skilled researcher with a strong background in orthopedic and neurosurgery research. Currently pursuing a Ph.D. at Taipei Medical University, he has demonstrated expertise in conducting meta-analyses and systematic reviews, as evidenced by his numerous publications in international journals. His research focuses on surgical techniques, implant materials, and risk factors in orthopedic surgery, particularly in spine and fracture management. Bao Tu’s work includes comparative studies of structural allografts versus synthetic materials in surgeries such as anterior cervical discectomy and fusion. He is also proficient in analyzing the impact of lifestyle factors like smoking on surgical outcomes. His proficiency in data analysis, medical statistics, and clinical research methodology has led to several international presentations. Bao Tu’s collaboration with leading academics in Taiwan and Vietnam further highlights his research capabilities, making him a well-rounded and impactful researcher in his field.

Award and Recognition

Bao Tu Thai Nguyen, a dedicated Ph.D. student at Taipei Medical University and a Lecturer and Attending Physician at Can Tho University of Medicine and Pharmacy, has demonstrated exceptional commitment to orthopedic research and education. His work includes numerous peer-reviewed publications, such as studies on anterior cervical discectomy and fusion, smoking-related surgical complications, and predictive models for surgical outcomes. Bao Tu’s research has gained international recognition, with presentations at prestigious conferences like the Japanese Orthopaedic Association and the European Federation of National Societies of Orthopaedics and Traumatology. His expertise in meta-analysis and contributions to the field of orthopedics have not only enriched academic knowledge but also impacted clinical practice, particularly in orthopedic surgery. Bao Tu’s academic achievements, clinical excellence, and research contributions position him as a highly deserving candidate for recognition and awards in the medical research community, showcasing his dedication to advancing orthopedic science globally.

Conclusion

Bao Tu Thai Nguyen, a dedicated Ph.D. student at Taipei Medical University and a Lecturer and Attending Physician at Can Tho University of Medicine and Pharmacy, has demonstrated exceptional commitment to orthopedic research and education. His work includes numerous peer-reviewed publications, such as studies on anterior cervical discectomy and fusion, smoking-related surgical complications, and predictive models for surgical outcomes. Bao Tu’s research has gained international recognition, with presentations at prestigious conferences like the Japanese Orthopaedic Association and the European Federation of National Societies of Orthopaedics and Traumatology. His expertise in meta-analysis and contributions to the field of orthopedics have not only enriched academic knowledge but also impacted clinical practice, particularly in orthopedic surgery. Bao Tu’s academic achievements, clinical excellence, and research contributions position him as a highly deserving candidate for recognition and awards in the medical research community, showcasing his dedication to advancing orthopedic science globally.

Publication Top Notes

  1. The Association between Red Blood Cell Distribution Width and Mortality Risk after Hip Fracture: A Meta-Analysis
    • Authors: Nguyen, B.T.T.; Tran, D.N.A.; Nguyen, T.T.; Kuo, Y.-J.; Chen, Y.-P.
    • Year: 2024
    • Journal: Medicina (Lithuania)
    • Volume/Issue: 60(3), 485
    • Citations: 3
  2. Adverse Effect of Smoking on Surgical Site Infection following Ankle and Calcaneal Fracture Fixation: A Meta-Analysis
    • Authors: Tran, D.N.A.; Nguyen, B.T.T.; Nguyen, T.T.; Chen, Y.-P.; Kuo, Y.-J.
    • Year: 2024
    • Journal: EFORT Open Reviews
    • Volume/Issue: 9(8), pp. 817–826
  3. Is Smoking a Risk Factor for Complications Following Total Ankle Arthroplasty? A Meta-Analysis
    • Authors: Le, Y.T.T.; Tran, D.N.A.; Nguyen, B.T.T.; Chen, Y.-P.; Kuo, Y.-J.
    • Year: 2024
    • Journal: Foot and Ankle Surgery (Article in Press)
  4. Two-port Endoscopic Surgery for Carpal Tunnel Syndrome – A Prospective Cohort Study
    • Authors: Nguyen, T.T.; Duong, K.; Tran, S.Q.; Ly, H.H.V.; Nguyen, B.T.T.
    • Year: 2022
    • Journal: Malaysian Orthopaedic Journal
    • Volume/Issue: 16(2), pp. 55–62
    • Citations: 2

 

 

 

Ting-Ting Chang | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Assoc Prof Dr. Ting-Ting Chang l Medicine and Dentistry l Best Researcher Award

Associate Professor at National Yang Ming Chiao Tung University, Taiwan

Dr. Ting-Ting Chang is an Associate Professor at National Yang Ming Chiao Tung University, specializing in vascular medicine, kidney disease, diabetes, and new drug development. With a Ph.D. from National Yang-Ming University, Dr. Chang has a robust publication record in high-impact journals, including Science Translational Medicine and Angiogenesis. Recognized with awards such as the Young Scientists Award and the Young Investigator Fellowship, Dr. Chang is also a full member of Sigma Xi and other prestigious societies. Their research is notable for its innovation and significant contributions to understanding and treating complex diseases.

Profile:

Education

Ting-Ting Chang, Ph.D., earned her Ph.D. in Pharmacology from National Yang-Ming University in Taipei, Taiwan, in 2015. Her educational journey is distinguished by her continued academic and research excellence, which laid a strong foundation for her current role as an Associate Professor in the Department and Institute of Pharmacology at National Yang Ming Chiao Tung University. Prior to this, Dr. Chang completed her post-doctoral research at the same institution, further solidifying her expertise in pharmacology and related fields.

Professional Experience

Ting-Ting Chang, Ph.D., is an accomplished researcher and academic with extensive experience in the field of pharmacology. Currently serving as an Associate Professor at the Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Dr. Chang has previously held roles as an Assistant Professor and Post-doctoral Researcher at the same institution. Their career spans significant contributions to vascular medicine, kidney disease, diabetes, and new drug development, with a track record of high-impact research and numerous publications in leading scientific journals.

Research Interest

Ting-Ting Chang’s research interests encompass a broad range of topics within vascular medicine and molecular biology, focusing on the mechanisms underlying vascular dysfunction, kidney disease, and diabetes mellitus. Her work includes experimental animal model design and new drug development, aiming to uncover novel therapeutic targets and strategies for these critical health issues. Dr. Chang’s research integrates molecular and cellular approaches to address complex pathological conditions, contributing significantly to advancements in understanding and treating vascular and metabolic disorders.

Research Skills

Ting-Ting Chang, Ph.D., demonstrates exceptional research skills through a robust portfolio of high-impact publications and significant contributions to fields such as vascular medicine, kidney disease, and diabetes. With a strong academic background and extensive experience as both an Associate Professor and Post-doctoral Researcher, Dr. Chang excels in designing and conducting innovative studies, particularly in identifying novel therapeutic targets and mechanisms. Their proficiency in experimental animal model design and new drug development further highlights their expertise, while their membership in prestigious scientific societies and receipt of notable awards underscore their recognition and influence in the research community.

Award and Recognition

Ting-Ting Chang, Ph.D., has garnered significant awards and recognition throughout their career, underscoring their outstanding contributions to research. Notably, Dr. Chang received the Young Scientists Award at the 55th Annual Scientific Meeting of the Japan Atherosclerosis Society in 2023 and the Young Investigator Fellowship Award at the 88th European Atherosclerosis Society Congress in 2020. In addition, Dr. Chang was awarded full membership of Sigma Xi in 2023, reflecting their esteemed position in the scientific community and their impactful research in vascular medicine, kidney disease, and diabetes.

Conclusion

Ting-Ting Chang, Ph.D., is a highly qualified candidate for the Best Researcher Award. Their exceptional contributions to vascular medicine, kidney disease, and diabetes, along with a strong publication record and recognition in the scientific community, underscore their suitability for this award. Addressing areas for improvement, such as expanding research applications and increasing public engagement, could further enhance their profile as a leading researcher. Overall, Dr. Chang’s dedication, innovative research, and professional achievements make them an excellent contender for the Best Researcher Award.

Publication Top Notes

  • Association between vitiligo and risk of retinal detachment: a population-based cohort study in Taiwan
    • Authors: Chen, C.-L., Wu, C.-Y., Chen, Y.-L., Chang, Y.-T., Wu, C.-Y.
    • Year: 2024
    • Citations: 0
  • Rejuvenation of the dorsal hand by injectable poly-D, L-lactic acid: A pilot study
    • Authors: Ma, S.-H., Lin, C.-Y., Lin, J.-Y., Chang, Y.-T., Chen, C.-C.
    • Year: 2024
    • Citations: 0
  • Correlation of Disease Severity, Proinflammatory Cytokines, and Reduced Brain Gray Matter Volumes in Patients with Atopic Dermatitis
    • Authors: Li, C.-Y., Chang, W.-C., Chen, M.-H., Chen, Y.-Y., Bai, Y.-M.
    • Year: 2024
    • Citations: 0
  • Risk of Type 1 Diabetes Mellitus in Patients with Atopic Dermatitis: A Nationwide Population-Based Cohort Study
    • Authors: Li, M.-C., Wu, C.-Y., Chang, Y.-T., Lyu, Y.-S., Wu, C.-Y.
    • Year: 2023
    • Citations: 0
  • Assoziation zwischen chronischer Nierenerkrankung und dem Risiko für bullöses Pemphigoid: eine nationale bevölkerungsbasierte Kohortenstudie
    • Authors: Yu, W.-T., Ma, S.-H., Wu, C.-Y., Chang, Y.-T., Wu, C.-Y.
    • Year: 2023
    • Citations: 1

Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Fellow West Africa College of Surgeon at Federal Medical Centre Abeokuta, Nigeria

Dr. Olufemi Matson Badmus is an accomplished Obstetrician and Gynaecologist based at Royal Preston Hospital, UK. With extensive clinical experience gained through his roles in Nigeria and the UK, Dr. Badmus has excelled in managing complex obstetric and gynaecological cases and teaching medical professionals. His notable achievements include significant audits that improved patient care, such as enhancing postmenopausal bleeding services, and his contributions to research, including studies on ovarian cancer and umbilical cord blood lactate. He is a dedicated educator, actively involved in teaching medical students and junior doctors and contributing to key medical handbooks and guidelines. Dr. Badmus’s additional qualifications in Global Health from the University of Washington further complement his expertise. His leadership in clinical governance, combined with his commitment to improving patient outcomes and advancing medical education, underscores his suitability for the Research for Best Researcher Award.

Profile

Education

Dr. Olufemi Matson Badmus earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) in 2009, laying the foundation for his medical career. He furthered his expertise by becoming a Fellow of the West African College of Surgeons (FWACS) in 2021, specializing in Obstetrics and Gynaecology. Dr. Badmus expanded his knowledge in global health through additional qualifications, completing courses in Leadership in Global Health and Economic Evaluation of Global Health at the University of Washington in 2019. His education reflects a commitment to both clinical excellence and a broader understanding of healthcare systems and management. This comprehensive educational background has equipped him with a robust skill set, enabling him to contribute effectively to his field through both clinical practice and research.

Professional Experience

Dr. Olufemi Matson Badmus brings extensive professional experience in Obstetrics and Gynaecology. Since March 2021, he has served as a Senior Clinical Fellow at Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, where he manages the labour ward, oversees obstetric emergencies, and performs complex procedures with remote supervision. Prior to this, Dr. Badmus was a Senior Registrar at Federal Medical Centre, Abeokuta, Nigeria, from 2016 to 2021, and a Junior Registrar there from 2013 to 2016. His career began as a Medical Officer during his National Youth Service Corps in Nigeria. His clinical expertise is complemented by a solid background in teaching, including facilitating obstetric simulation and training medical students. Dr. Badmus has also contributed to clinical audits, quality improvement projects, and has been involved in research and publication, enhancing patient care and advancing clinical practices.

Research Interest

Dr. Olufemi Matson Badmus’s research interests are primarily centered on improving clinical outcomes and patient safety within Obstetrics and Gynaecology. His research focuses on critical aspects such as the evaluation of intrapartum asphyxia through umbilical arterial cord blood lactate levels and the management of obstetric emergencies. Dr. Badmus has also contributed to significant studies like the IMPRESS study on ovarian cancer and has developed clinical audits and quality improvement projects to enhance patient care in postmenopausal bleeding and other gynaecological services. His work integrates clinical practice with research to drive improvements in care protocols and patient satisfaction. Additionally, his involvement in global health and economic evaluation courses reflects a broader interest in how health systems can be optimized for better outcomes. Dr. Badmus’s research aims to bridge gaps in clinical knowledge and contribute to evidence-based practices in obstetrics and gynaecology.

Research Skills

Dr. Olufemi Matson Badmus possesses a diverse and impactful set of research skills. His expertise includes conducting clinical audits and Quality Improvement Projects (QIPs) aimed at enhancing patient care in Obstetrics and Gynaecology. Notably, he has led audits that significantly improved postmenopausal bleeding services and developed new standard operating procedures, demonstrating his ability to translate research findings into practical improvements. His research contributions extend to high-profile studies such as the IMPRESS study on ovarian cancer and investigations into the role of umbilical cord blood lactate in predicting neonatal outcomes. Dr. Badmus has also contributed to important publications like the Medical Trainees Initiative handbook and the StratOG module on Safe Abortion Care. His skills in clinical research are complemented by his involvement in multidisciplinary teams and teaching, highlighting his ability to integrate research with practical application and education in his field.

Award and Recognition

Dr. Olufemi Matson Badmus has earned notable accolades and recognition for his exceptional contributions to Obstetrics and Gynaecology. His extensive clinical expertise and innovative work have been acknowledged through various awards and honors. Dr. Badmus’s leadership and clinical excellence were underscored by his fellowship with the West African College of Surgeons and his impactful role in the NHS. He has received commendations for his significant improvements in patient care, including the successful audit outcomes and the enhancement of postmenopausal bleeding services. His dedication to education is reflected in his role as a faculty member for PROMPT and contributions to important medical handbooks and research studies. Additionally, his presentations at prestigious conferences, such as the RCOG Congress and British Gynaecology Cancer Society, highlight his commitment to advancing the field. These achievements collectively underscore Dr. Badmus’s standing as a distinguished and respected figure in his field.

Conclusion

Dr. Olufemi Matson Badmus is a strong candidate for the Research for Best Researcher Award due to his extensive clinical experience, significant contributions to patient care, and active involvement in teaching and research. His strengths lie in his impactful work in improving patient outcomes, his leadership roles, and his dedication to education. Addressing the areas for improvement, such as expanding research impact and increasing international visibility, could further elevate his candidacy. Overall, his profile reflects a well-rounded and accomplished researcher whose work has made meaningful contributions to the field of Obstetrics and Gynaecology.

Publications Top Notes

Umbilical Arterial Blood Lactate as Predictor of Early Neonatal Outcome and Evaluation of Intrapartum Asphyxia

  • Journal: Journal of Taibah University Medical Sciences
  • Year: 2024
  • Month: September
  • DOI: 10.1016/j.jtumed.2024.08.027
  • Authors: Olufemi M. Badmus, Olaide R. Adenaya, Oluseyi A. Aderinwale, Bernard O. Ewuoso, Babatunde S. Awolaja, Adedoyin O. Ade-Onojobi

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79